Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
Here, the authors identify interleukin-3 as a predictive marker for severity and outcome of SARS-CoV-2 infection in a multi-center, prospective study and find that patients with severe COVID-19 have reduced circulating plasmacytoid dendritic cell levels compared to non-severe COVID-19 patients.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da75b62b7c584d48a9ba0f701d8cd0cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:da75b62b7c584d48a9ba0f701d8cd0cf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:da75b62b7c584d48a9ba0f701d8cd0cf2021-12-02T14:03:49ZInterleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections10.1038/s41467-021-21310-42041-1723https://doaj.org/article/da75b62b7c584d48a9ba0f701d8cd0cf2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21310-4https://doaj.org/toc/2041-1723Here, the authors identify interleukin-3 as a predictive marker for severity and outcome of SARS-CoV-2 infection in a multi-center, prospective study and find that patients with severe COVID-19 have reduced circulating plasmacytoid dendritic cell levels compared to non-severe COVID-19 patients.Alan BénardAnne JacobsenMaximilian BrunnerChristian KrautzBettina KlöschIzabela SwierzyElisabeth NaschbergerMalgorzata J. PodolskaDina KouhestaniPaul DavidTorsten BirkholzIxchel CastellanosDenis TrufaHoria SirbuMarcel VetterAndreas E. KremerKai HildnerAndreas HeckerFabian EdingerMatthias TenbuschPetra Mühl-ZürbesAlexander SteinkassererEnrico RichterHendrik StreeckMarc M. BergerThorsten BrennerMarkus A. WeigandFilip K. SwirskiGeorg SchettRobert GrützmannGeorg F. WeberNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Alan Bénard Anne Jacobsen Maximilian Brunner Christian Krautz Bettina Klösch Izabela Swierzy Elisabeth Naschberger Malgorzata J. Podolska Dina Kouhestani Paul David Torsten Birkholz Ixchel Castellanos Denis Trufa Horia Sirbu Marcel Vetter Andreas E. Kremer Kai Hildner Andreas Hecker Fabian Edinger Matthias Tenbusch Petra Mühl-Zürbes Alexander Steinkasserer Enrico Richter Hendrik Streeck Marc M. Berger Thorsten Brenner Markus A. Weigand Filip K. Swirski Georg Schett Robert Grützmann Georg F. Weber Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections |
description |
Here, the authors identify interleukin-3 as a predictive marker for severity and outcome of SARS-CoV-2 infection in a multi-center, prospective study and find that patients with severe COVID-19 have reduced circulating plasmacytoid dendritic cell levels compared to non-severe COVID-19 patients. |
format |
article |
author |
Alan Bénard Anne Jacobsen Maximilian Brunner Christian Krautz Bettina Klösch Izabela Swierzy Elisabeth Naschberger Malgorzata J. Podolska Dina Kouhestani Paul David Torsten Birkholz Ixchel Castellanos Denis Trufa Horia Sirbu Marcel Vetter Andreas E. Kremer Kai Hildner Andreas Hecker Fabian Edinger Matthias Tenbusch Petra Mühl-Zürbes Alexander Steinkasserer Enrico Richter Hendrik Streeck Marc M. Berger Thorsten Brenner Markus A. Weigand Filip K. Swirski Georg Schett Robert Grützmann Georg F. Weber |
author_facet |
Alan Bénard Anne Jacobsen Maximilian Brunner Christian Krautz Bettina Klösch Izabela Swierzy Elisabeth Naschberger Malgorzata J. Podolska Dina Kouhestani Paul David Torsten Birkholz Ixchel Castellanos Denis Trufa Horia Sirbu Marcel Vetter Andreas E. Kremer Kai Hildner Andreas Hecker Fabian Edinger Matthias Tenbusch Petra Mühl-Zürbes Alexander Steinkasserer Enrico Richter Hendrik Streeck Marc M. Berger Thorsten Brenner Markus A. Weigand Filip K. Swirski Georg Schett Robert Grützmann Georg F. Weber |
author_sort |
Alan Bénard |
title |
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections |
title_short |
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections |
title_full |
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections |
title_fullStr |
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections |
title_full_unstemmed |
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections |
title_sort |
interleukin-3 is a predictive marker for severity and outcome during sars-cov-2 infections |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/da75b62b7c584d48a9ba0f701d8cd0cf |
work_keys_str_mv |
AT alanbenard interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT annejacobsen interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT maximilianbrunner interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT christiankrautz interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT bettinaklosch interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT izabelaswierzy interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT elisabethnaschberger interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT malgorzatajpodolska interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT dinakouhestani interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT pauldavid interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT torstenbirkholz interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT ixchelcastellanos interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT denistrufa interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT horiasirbu interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT marcelvetter interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT andreasekremer interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT kaihildner interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT andreashecker interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT fabianedinger interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT matthiastenbusch interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT petramuhlzurbes interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT alexandersteinkasserer interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT enricorichter interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT hendrikstreeck interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT marcmberger interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT thorstenbrenner interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT markusaweigand interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT filipkswirski interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT georgschett interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT robertgrutzmann interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections AT georgfweber interleukin3isapredictivemarkerforseverityandoutcomeduringsarscov2infections |
_version_ |
1718392112793255936 |